ERNA
ERNA
NASDAQ · Biotechnology

Ernexa Therapeutics Inc

$1.79
-0.14 (-7.25%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,619.0% upside
Low Target $21.48
Average Target $30.77
High Target $35.71
Current Price $1.79
Current
$1.79
Target
$30.77
$21.48 $30.77 avg $35.71
Scenario Analysis
Bear Case
$21.48
1,100.0%
Low target
Base Case
$30.77
+1,619.0%
Avg target
Bull Case
$35.71
+1,895.0%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$46.00
-96.1% from high
52-Week Low
$1.74
+2.9% from low
Target vs 52W High
$30.77
-33.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%